We established a factor-independent acute myeloid leukemia penia, general weakness, mucosal bleeding and fever. AML Cells were cultured in RPMI 1640 media (Gibco BRL, EggKeywords: acute myeloid leukemia line; FAB M3; wt-1 and bcl-2 expression; factor independent growth enstein, Germany) supplemented with 10% FCS (Roth, Karlsruhe, Germany), 1% penicillin-streptomycin (Gibco BRL) and 2% L-glutamine (Gibco BRL) in 24-well plates (Costar, Introduction Cambridge, MA, USA) at a concentration of 0.5 × 10 6 /ml. After several weeks of culture, cells grew out and were transAcute myeloid leukemia (AML) is a frequent hematological ferred in 50 ml tissue culture flasks (Nunc, Wiesbaden, neoplasm in adults and although considerable progress in the Germany) where they could be maintained or expanded by treatment of the disease has been made, the majority of the addition of the described media. patients die.
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1 Despite substantial research efforts, the pathogenesis of AML is still unclear. To study pathogenetic mechStaining and cytochemical analysis anisms in AML blasts is difficult to attempt, because these cells usually cannot be maintained in culture, even with the Pappenheim, myeloperoxidase, esterase, and PAS stainings of addition of hematopoietic growth factors.
2 Therefore AML cell cytospins were performed using standard procedures. lines are advantageous tools to study pathogenesis and response of blasts to therapeutic agents.
3, 4 We established an AML-derived cell line and characterized the karyotype and a Immunophenotyping number of molecular features of this line. The Ei501 cell line grows independently from growth factors and presents a numCell surface analysis was performed by flow cytometry with ber of characteristics, which are common in blast cells from a FACScan (Becton Dickinson, Heidelberg, Germany) using AML patients and other AML cell lines. In the present report monoclonal antibodies aginst CD13, CD33, CD34, CD38, we describe the AML cell line Ei501, which may be a tool for CD45, HLA-DR, HLA ABC, CD25, TU27 (Becton Dickinson), future investigations in AML.
CD11a, CD18, CD29, CD54 and IL-4 R (Dianova, Hamburg, Germany). A monoclonal antibody against myeloperoxidase was purchased from Dako (Hamburg, Germany) and the intraCase history cellular analysis was performed exactly according to the manufacturer's instructions. The 17-year-old patient was admitted to the hospital in December 1994 with leukocytosis, anemia and thrombocytoReverse-transcriptase polymerase chain reaction (RT-PCR)
Correspondence: E Weidmann, Medical Clinic III, Department of Internal Medicine, University Hospital, Theodor-Stern- Kai 7, 60590 The RT-PCR was performed as described elsewhere.
5,6 RNA 710 To control the integrity of the RNA, each cDNA was PCR amplified using primers for the house-keeping gene ␤-actin. The cDNA synthesized as described above was amplified by PCR using oligonucleotide primers as described (IL-2R, 8 TGF-␤ 9 , wt-1 10, 11 ). IL-2, IFN-␥, IL-4, IL-10, IL-12 and bcl-2 primers were designed according to published sequences as follows: 
5Ј5Ј-CCGCTACCGCCGCGACTTC-3′
HLA-ABC ND 98 CD25 0 0
(synthesis by MWG Biotech, Ebersberg, Germany).
The reaction was performed in solution containing cDNA Triton X-100 in a total volume of 50 l. Thirty-five PCR cycles Myeloperoxidase 100 100
were performed with 30 s denaturation at 94°C, with 30 s annealing at suitable temperatures and with 30 s extension at Surface molecules were analyzed using monoclonal antibodies at 72°C. Reagent controls using H 2 O and positive controls using diagnosis and after 10 months of culture.
cDNA from activated lymphocytes or the established HEL line were performed with each reaction. The amplified products were separated and visualized in ethidium bromide stained Germany) as described. 7 For cDNA synthesis, aliquots of 5 g total RNA were reverse transcribed. RNA was incubated for 1% agarose gels. The performed PCRs are routine procedures in our laboratory and the identity of the amplified products 30 min at 42°C with a mixture of 200 U of Moloney leukemia virus reverse transcriptase (MMLV-RT), 2 g oligo-dT, 1 mM was confirmed by Southern blotting 12 when the PCRs were initially established. dNTP, 1 l DTT 100 mM, 30 U RNAse inhibitor, 6 l 711 minus spontaneous effector cell LDH release; S = spontaneous target cell LDH release; and M = total target cell LDH release.
Lysis of the line was tested with lymphocytes from an AML patient treated with interleukin 2 (patient 1) and lymphocytes from three healthy donors (HD) activated in vitro with 600 IU IL-2/ml for 3 days. ND, not done.
Results and discussion
Blast cells obtained from the initial bone marrow aspiration LDH release assay for cytotoxic activity at diagnosis of the disease were isolated and cultured as described in Methods. Unlike blasts from most AML patients, LDH release assay was carried out as described by us earlier. 13 Briefly, target and effector cells were washed and transferred after 4 weeks a blast population grew out and could be maintained as a single cell suspension culture without addition of into phenol red-free RPMI 1640 (Gibco). The assay was performed in 96-well round-bottom plates (Nunc, Wiesbaden, growth factors. Since then, the Ei501 line has been cultured continuously for 18 months, but has also been frozen and Germany). Target cells were incubated with effector cells in triplicates at different effector:target ratios for 3 h at 37°C. thawed repeatedly. In culture, the doubling time at optimal cell density of approximately 0.3-0.5 × 10 6 cells/ml ranged Spontaneous LDH release of effector or target cells was controlled by separate incubation of the respective population.
between 3 and 4 days (data not shown). Histochemical and cytogenetic features did not change after the cell line was Total LDH release was determined after lysis with 1% Triton X-100 (Sigma, Munich, Germany). After centrifugation of the established. Myeloperoxidase was 100% positive and esterase and PAS were negative. The morphology of the patient's bone plates, a 100 l aliquot was transferred into another 96-well plate and 100 l LDH substrate solution (5.4 × 10 −2 M lactate, marrow blasts and the line is shown in Figure 1a and (Figure 2 ). The cytogenetic analysis was confirmed by FISH technique (Figure 3 ). These chromosome aberrations were not was added to each well. The plates were incubated light protected at room temperature for 10 min, and then the reaction identical to those in the cytogenetic analysis performed at
Figure 2
Cytogenetic analysis of the Ei501 cell line, using G-banding according to ISCN recommendation. Arrows indicate the chromosome aberrations.
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In order to study immunologic features of the cell line RNA expression of various cytokines was studied by RT-PCR. The line did not express mRNA for immune stimulatory cytokines such as IL-2, IL-4 or IL-12, however, there was a distinct signal for TGF-␤, which has been shown by us 9 and others 20,21 to suppress the immune system of tumor patients, in our case especially the lytic activity of IL-2-activated cytotoxic lymphocytes in AML patients. However, TGF-␤ protein was not detectable in ELISA assays (data not shown).
Although the line did not produce interleukin-2, message for the IL-2 receptor ␤ and ␥ chains was amplified by RT-PCR, whereas, according to the surface molecule studies, ␣ chain mRNA was not detectable (Tables 1 and 2 ). The role of IL-2 receptors on AML blasts is still unclear. We recently demonstrated that IL-2 receptors are variably expressed on AML blasts, 8 but in accordance with other groups 22, 23 we did not find functional consequences in response to IL-2. 8 Whether the IL-2R-␥ chain expression by the Ei501 line may be functionally associated with the IL-4 receptor (Table 1) The Ei501 cell line also expressed the genes for the protoprobes WCP15 and WCP17 were obtained from VYSIS (Tü bingen, oncogene bcl-2 and for the tumor suppressor gene wt-1
Germany) and FISH was performed according to the instructions of (Wilms' tumor gene), both common in AML. We and others VYSIS. have shown that the tumor suppressor gene wt-1 (Wilms' tumor gene) and the proto-oncogene bcl-2 are expressed in blast cells of the majority of cases with AML. 11, [24] [25] [26] The funcdiagnosis, most likely because of misinterpretation of the initial karyotype. This and the morphological and cytochemtion of these genes in AML remains to be elucidated. Expression of bcl-2 has been discussed to be associated with ical appearance led to the diagnosis of FAB M2 leukemia. The function of chromosome aberrations in AML is the object of poorer response to treatment by protection of blasts against apoptosis. 27 Therefore, further studies of these genes may help extensive research, demonstrating that certain translocations, such as t(15;17) in AML M3 or t(8;21) in AML M2 patients are to increase the insight into the biology of AML blasts. Table 3 demonstrates that the blast cell line may also be associated with better prognosis and that trisomias or multiple aberrations go along with poor prognosis. [14] [15] [16] [17] Recently, a proused as a target for cytotoxicity assays. It shows the results of a representative experiment in an AML patient who underwent myelocytic leukemia cell line with a t(15;17) and additions to chromosomes 1, 6 and 7 has been described. 18 This line has treatment with IL-2. Lymphocytes were isolated following IL-2 therapy and tested for their ability to lyse AML cells using been shown to carry a point mutation in the retinoic acid receptor, possibly responsible for a lack of differentiation in various effector to target ratios in an LDH release assay. In another experiment lymphocytes were obtained from three response to retinoic acid. The role of the other chromosome aberrations remained speculative. An AML M2 cell line healthy volunteers and cultured with IL-2 for 3 days. The fact that the line is lysable by IL-2-activated lymphocytes may be (SKNO-1) carrying the t(8,21) translocation has been shown to express p53 with a point mutation. Since inactivated p53 relevant in respect to upcoming clinical protocols using IL-2 for induction of cytotoxic cells against residual blast popumay be involved in progression of AML, the line has been proposed as a model for studies of molecular mechanisms in lations in patients with AML.
28,29
In conclusion, we established a new AML cell line with AML. 19 Whether or not the chromosome constellation of the Ei501 cell line may have functional effects or may have influt(15;17), common in FAB M3 and an additional t(7;8). Besides the karyotype, the line has a number of characteristics comenced the prognosis of the patient will have to be clarified.
Analysis of surface molecule expression showed some mon in AML. Thus, Ei501 cells may be suitable for further studies regarding the pathophysiology of AML. selection in culture. After 10 months in culture, CD13, CD33, CD45, CD29 and myeloperoxidase were expressed at constantly high levels ( Table 1 ). The AML associated surface markers CD34 and CD38 changed during in vitro culture. ProbAcknowledgements ably as a consequence of selection or the disappearance of some maturation blast cells expressing the stem cell marker This work was supported in parts by a grant from the Deutsche Forschungsgemeinschaft We 1335/2-1 and by the Adolf CD34, whereas CD38 was expressed by all cells of the line (Table 1) . Class I molecules were present on all cells and the Messer Stiftung. The authors wish to thank Mrs S Christ, Mrs S Finkler and Mrs B Kalt for excellent technical assistance. class II molecule HLA-DR increased during culture. Surface adhesion molecules CD11a, CD18, CD29 and CD54 were highly positive and, except CD29, their expression increased in culture ( 
